Microarray studies on effects of Pneumocystis carinii infection on global gene expression in alveolar macrophages by Cheng, Bi-Hua et al.
RESEARCH ARTICLE Open Access
Microarray studies on effects of Pneumocystis
carinii infection on global gene expression in
alveolar macrophages
Bi-Hua Cheng
1,2, Yunlong Liu
3,4,5, Xiaoling Xuei
5,6, Chung-Ping Liao
7, Debao Lu
8, Mark E Lasbury
7,
Pamela J Durant
7, Chao-Hung Lee
7,9*
Abstract
Background: Pneumocystis pneumonia is a common opportunistic disease in AIDS patients. The alveolar
macrophage is an important effector cell in the clearance of Pneumocystis organisms by phagocytosis. However,
both the number and phagocytic activity of alveolar macrophages are decreased in Pneumocystis infected hosts. To
understand how Pneumocystis inactivates alveolar macrophages, Affymetrix GeneChip® RG-U34A DNA microarrays
were used to study the difference in global gene expression in alveolar macrophages from uninfected and
Pneumocystis carinii-infected Sprague-Dawley rats.
Results: Analyses of genes that were affected by Pneumocystis infection showed that many functions in the cells
were affected. Antigen presentation, cell-mediated immune response, humoral immune response, and
inflammatory response were most severely affected, followed by cellular movement, immune cell trafficking,
immunological disease, cell-to-cell signaling and interaction, cell death, organ injury and abnormality, cell signaling,
infectious disease, small molecular biochemistry, antimicrobial response, and free radical scavenging. Since rats
must be immunosuppressed in order to develop Pneumocystis infection, alveolar macrophages from four rats of
the same sex and age that were treated with dexamethasone for the entire eight weeks of the study period were
also examined. With a filter of false-discovery rate less than 0.1 and fold change greater than 1.5, 200 genes were
found to be up-regulated, and 144 genes were down-regulated by dexamethasone treatment. During Pneumocystis
pneumonia, 115 genes were found to be up- and 137 were down-regulated with the same filtering criteria. The
top ten genes up-regulated by Pneumocystis infection were Cxcl10, Spp1, S100A9, Rsad2, S100A8, Nos2, RT1-Bb,
Lcn2, RT1-Db1, and Srgn with fold changes ranging between 12.33 and 5.34; and the top ten down-regulated ones
were Lgals1, Psat1, Tbc1d23, Gsta1, Car5b, Xrcc5, Pdlim1, Alcam, Cidea, and Pkib with fold changes ranging
between -4.24 and -2.25.
Conclusions: In order to survive in the host, Pneumocystis organisms change the expression profile of alveolar
macrophages. Results of this study revealed that Pneumocystis infection affects many cellular functions leading to
reduced number and activity of alveolar macrophages during Pneumocystis pneumonia.
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Pneumocystis pneumonia (PCP) is the most common
opportunistic disease in AIDS patients [1,2]. During the
early stage of the AIDS epidemic, PCP occurred in 60-80%
of HIV infected patients in the United States and Western
Europe [3]. Characteristic pathology features of PCP
include infiltration of inflammatory cells in the lung, thick-
ened alveolar septa, and foamy exudates in the alveoli.
Since Pneumocystis has a typical morphology of proto-
zoa, it was initially considered as protozoa. It is now
classified as a fungus because the composition and
structure of its cell wall [4,5] and nucleotide sequences
are more similar to those of fungi than to those of pro-
tozoa [6-9]. Although Pneumocystis organisms are found
in many different species of mammals, they are strictly
species specific [10]. Therefore, Pneumocystis from dif-
ferent host species has different names [11]. Among the
more common ones, human Pneumocystis is called
Pneumocystis jirovecii.R a tPneumocystis is referred to
as P. carinii;a n o t h e rr a tPneumocystis strain is called
P. wakefieldii. Mouse Pneumocystis is named P. murina.
In immunocompetent humans and animals, alveolar
macrophages (AMs) protect the hosts against Pneumo-
cystis infection by actively removing this extracellular
organism from the alveoli. However, AMs from Pneu-
mocystis-infected animals are defective in phagocytosis
[12,13], and the number of AMs in humans and animals
with PCP is reduced [14-16]. These two defects impair
the innate immunity against Pneumocystis infection. The
reduction in alveolar macrophage (AM) number is
mainly due to increased rate of apoptosis [17]. A recent
study demonstrates that increased levels of intracellular
polyamines trigger this apoptosis [18].
The increase in polyamine levels in AMs is due to
increased de novo synthesis and uptake of exogenous
polyamines [19]. Very little is known about the defect in
phagocytosis during PCP. Decreased expression of
macrophage receptors such as mannose receptor is a
possible cause [20]. In this study, we used DNA micro-
arrays to study global gene expression in AMs from
P. carinii-infected rats to better understand the mechan-
isms of pathogenesis of PCP.
Methods
Rat PCP Model
P. carinii infection in rats was established as described
previously [21]. Briefly, female Sprague-Dawley rats
(Harlan, Indianapolis, IN) of 120-140 g were divided
into three groups designated Normal, Dex, and Dex-Pc
rats. Normal rats were immunocompetent and unin-
fected. Since rats must be immunosuppressed in order
to develop PCP upon inoculation of Pneumocystis
organisms, they were immunosuppressed by giving dex-
amethasone (1.8 mg/liter) continuously in drinking
water to reduce the number of CD4+ T lymphocytes.
These rats were referred to as Dex rats. Although the
Dex rats were continuously immunosuppressed for nine
weeks, they showed no signs of disease. Dex-Pc rats
were Dex rats transtracheally inoculated with 7.5 × 10
6
P. carinii organisms one week after initiation of immu-
nosuppression. To prevent other opportunistic infec-
tions, immunosuppressed rats were given 10,000 units
of penicillin (Butler, Dublin, OH) weekly by intramuscu-
lar (i.m.) injection. All P. carinii-infected rats showed
signs of PCP including weight loss, dark eyes, hunched
posture, and respiratory distress eight weeks after inocu-
lation of the organisms and were sacrificed for isolation
of AMs. Age-matched Normal rats were used as con-
trols, while age-matched Dex rats were used to control
for effect of the steroid treatment. Giemsa and silver
staining of lung impression smears was performed to
determine the existence of Pneumocystis and other
microorganisms. Any lungs that contained other micro-
organisms were excluded. All animal studies were
approved by the Indiana University Animal Care and
Use Committee and supervised by veterinarians.
Isolation of alveolar macrophages
Rats were anesthetized by i.m. injection of 0.1 ml keta-
mine mixture (80 mg/ml ketamine hydrochloride, 0.38
mg/ml atropine, and 1.76 mg/ml acepromazine) and then
sacrificed. The thoracic cavity and trachea were exposed
by dissection. Bronchoalveolar lavage fluid (BALF) was
obtained by instilling 5 ml of sterile phosphate buffered
saline (PBS) one at a time into rat lungs with a 14-gauge
angiocath (BD Biosciences, Bedford, MA) and then recov-
ered until a total of 50 ml BALF was obtained [22]. The
cells in this 50-ml BALF were pelleted by centrifugation
at 300 × g for 10 min and then resuspended in 5 ml of
Dulbecco’s Modified Eagle Medium (DMEM). AMs were
isolated by adherence on plastic tissue culture dishes at
37°C with 5% CO2 for 1 hr followed by washing with
warm PBS three times to remove unattached cells. The
purity of AMs was greater than 97% as determined by
anti-RMA staining described previously [23].
Isolation of RNA from alveolar macrophages
AMs from four each of Normal, Dex, and Dex-Pc rats
were used. Total RNA was isolated individually from
each sample using the RNeasy kit (Qiagen) according to
manufacturer’s instructions. Approximately 2 × 10
6 cells
from each animal were used. The cells were washed
with PBS and then lysed with 350 μl of Buffer RLT in
the kit. The cell lysate was passed five times through a
20 gauge needle and then through the Genomic DNA
Eliminator spin column by centrifugation, followed by
addition of 350 μl of 70% ethanol to the flow through.
The mixture was transferred to an RNeasy spin column
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discarded after a 15 s centrifugation at 8000 × g.T h e
column was washed with 700 μl of Buffer RW1 and
then with 500 μl of Buffer RPE twice. Total RNA was
eluted from the column with 30 μl of RNase-free water
and quantified by spectrophotometer.
Microarray analysis
The Affymetrix GeneChip® RG-U34A, containing 8799
rat genes and EST sequences, was used for the microar-
ray analysis. Briefly, 2.5 μg of total RNA from each rat
was reversely transcribed, using the standard 3’IVT pro-
tocol as described previously [24], and hybridized to a
GeneChip. A total of 12 GeneChips were used, four for
each sample group from Normal, Dex, and Dex-Pc rats.
The data were first analyzed with Microarray Suite ver-
sion 5.0 (MAS 5.0) using Affymetrix default analysis set-
tings and global scaling as normalization method. The
trimmed mean target intensity of each array was arbitra-
rily set to 1000. Comparisons of global gene expression
and identification of genes that were up- or down-regu-
lated by dexamethasone treatment or by P. carinii infec-
tion in AMs from the three different groups of rats
(Normal, Dex, and Dex-Pc) were performed with the
Partek Genomic Suite 6.4 Software (Partek Inc., St.
Louis, MO). Identification of cellular functions affected
by dexamethasone or Pneumocystis infection was
achieved by using the Ingenuity Pathway Analysis (IPA)
software (Ingenuity Systems Inc. Redwood City, CA).
The microarray data generated in this study have been
deposited in the Gene Expression Omnibus with the
accession number GSE20149.
Real-time RT-PCR
Approximately 0.2 μg of each total AM RNA sample
was reversely transcribed to cDNA using the iScript
cDNA synthesis kit (Bio-Rad, Hercules, CA) and ran-
dom primers in a total reaction volume of 20 μl. The
reaction mixtures were incubated at 25°C for 5 min, 42°
Cf o r3 0m i n ,a n d8 5 ° Cf o r5m i n .O ft h i s ,2μl of each
cDNA product was used for quantitative PCR analysis.
Real-time RT-PCRs for various target genes were per-
formed using the Assays-on-Demand™ gene expression
kits. Each kit contained two unlabeled PCR primers and
aF A M ™-labeled TaqMan probe (Applied Biosystems,
Foster City, CA). Since the expression of the ribosomal
protein S8 (RPS8) is not affected by Pneumocystis infec-
tion, RPS8 mRNAs were assayed in an identical manner
as an internal control as described previously [25].
Results
Quality of microarray data
Since each GeneChip contained 8799 probe sets, a total
of 105,588 expression data points were generated from
the twelve arrays. Principle component analysis (PCA)
was first performed to examine the correlations among
the data produced from different arrays. The results of
the first three principal components, which included the
variance of 83.5% of the expression data points of each
sample, are shown in Fig. 1. Each blue, red, or green dot
represents the overall expression pattern of each AM
sample from Normal, Dex, or Dex-Pc rats, respectively
(Fig. 1). The PCA analysis showed that the samples
within each rat group were closely clustered together,
whereas the samples between rat groups were distinctly
separated, indicating that the quality of the microarray
data was excellent. The PCA results also indicated that
the global expression patterns in AMs of the same rat
group were similar, whereas those in AMs of different
rat groups were different.
Hierarchical clustering analysis of differentially expressed
genes
After ANOVA, 3473 genes were found to be differen-
tially expressed due to dexamethasone treatment or
Pneumocystis infection and were analyzed by hierarchi-
cal clustering using the Partek software (Fig. 2). Genes
that were differentially expressed due to Pneumocystis
infection were divided into four categories. The first one
includes genes whose expressions were not affected by
Pneumocystis infection. The second category includes
those that were expressed at low levels but were up
regulated by Pneumocystis infection. The third category
contains genes that were expressed at high levels and
were not affected by Pneumocystis infection. The fourth
category includes those that were expressed at high
levels but were down regulated by Pneumocystis infec-
tion. The same four categories of gene expressions in
AMs from dexamethasone treated rats were observed.
Functional pathways affected by dexamethasone or
Pneumocystis infection
To ensure the accuracy of the results, only the differen-
tially expressed genes with a false-discovery rate (FDR)
≤ 0.1 and a fold change (FC) ≥ 1.5 were further ana-
lyzed. With IPA, the following functions were found to
be significantly affected by dexamethasone (listed in the
order of significance from highest to lowest): cell death,
small molecular biochemistry, immunological disease,
cellular movement, cell-to-cell signaling and interaction,
immune cell trafficking, antigen presentation, cell-
mediated immune response, humoral immune response,
inflammatory response, respiratory disease, cell signal-
ing, infectious disease, organ injury and abnormality,
and free radical scavenging. These functions were also
affected by Pneumocystis infection, but in a different
order of significance (also listed in the order of signifi-
cance from highest to lowest): antigen presentation, cell-
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and inflammatory response were equally and most
severely affected, followed by cellular movement,
immune cell trafficking, immunological disease, cell-to-
cell signaling and interaction, cell death, organ injury
and abnormality, cell signaling, infectious disease, small
molecular biochemistry, antimicrobial response, and free
radical scavenging (Fig. 3).
The functions that were affected by Pneumocystis infec-
tion were further classified into four major groups:
immune response, inflammation, cell death, and phagocy-
tosis (Fig. 4). The immune response group included cell-
mediated immune response, humoral immune response,
and antigen presentation. The cell death group included
cell death and organ injury and abnormality; while cell
signaling, cell-to-cell interaction, cell movement, anti-
microbial response, immune cell trafficking, and free radi-
cal scavenging were included in the phagocytosis group.
Genes that were differentially expressed due to Pneumo-
cystis infection not dexamethasone treatment in each
group are shown in Table 1. It is interesting to note that
these four functions share many of the same genes.
Among these, Lgals1, Alcam, and Cd55 genes were down
regulated; while Sod2, Soc3, Prf1, Il10, Mmp7, Sell,
Psmb9, Oas1a, Clu, Ccr1, Mx1, Il8rb, Ccr5, Ccl5, Irf7,
Nos2, and Cxcl10 genes were up regulated in all four
functional groups. Cat and Hip1 genes that belong to
both the cell death and phagocytosis groups were down
regulated. In the cell death group, Hdac2, Bnip3L, Nr1h3,
and Ppp6C genes were down regulated, and the Tap2
gene was up regulated. Mmp14 and Mmp8 in all but the
immune response group, Mx2 in both immune response
and phagocytosis groups, Gbp2 in both immune response
and inflammation groups, and Tap1 in the immune
response group were up-regulated.
Among the genes that were affected by dexametha-
sone and further affected by Pneumocystis infection,
Mgst1 and Hspa1b genes were down-regulated, while
Cd14, Irf8, Il1b, Cxcl13, Cxcr4, Fn1, Irf1, Cd74, S100a9,
and Spp1 genes were up-regulated in all four groups
Figure 1 Principle component analysis of microarray results. The blue, red, and green oval dots represent linear combinations of the
expression data, including relative expression value and variance, of the 8799 genes in AMs from each Normal, Dex, or Dex-Pc rat. The principle
component analysis (PCA) software examined three components of genes in different samples for those with similar or different expression
profiles. The first component, shown in the x-axis, includes genes with a high degree of variance. The second component, displayed in the y-
axis, encompasses genes that had a median range of variance. The third component, represented by z-axis, contains those with a minor
variance.
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some groups: Pld1 and Xdh in both cell death and pha-
gocytosis; C1qb in both immune response and inflam-
mation groups; Alox5 in all but the inflammation group;
and Srgn in both immune response and cell death
groups. Genes that were down-regulated in some groups
include: Gnptg, Fah, Bloc1s2, and Prkacb in the cell
death group; Dnaja1 in both cell death and phagocytosis
groups; Tfp1 in all but the cell death group; Alox5 in all
but the inflammation group; and Mmp12 in all but the
immune response group.
Subcellular locations of differentially expressed genes
Among the proteins encoded by the genes whose
expressions were affected by both dexamethasone and
Pneumocystis in the four functional groups, IL1B, IL10,
SRGN, MMP12, SPP1, and C1QB are secreted. CD74,
CXCR4, SIRPA, FN1, and CD14 are membrane proteins,
w h i l eM G S T 1 ,X D H ,P L D 1 ,S 1 0 0 A 9 ,G N P T G ,P T P N 6 ,
ALOX5, FAH, PLDN, and PRKACB proteins are located
in the cytoplasm. IRF1, IRF8, DNAJA1, and NR0B2 are
nuclear proteins (Fig. 5). Both IL-1B and IL-10 have a
direct relationship with IRF1 and may affect its expres-
sion. IL-10 has an indirect relationship with IRF8, and
IRF8 can regulate the expression of IL-1B. Except for
Mgst1, Alox5, Fah, Pldn, Prkacb, Dnaja1, and Nrob2, all
other genes are shown to have direct or indirect rela-
tionships between each other. This analysis also revealed
four key proteins including IL-1B, IL-10, IRF1, and IRF8
that are central to the regulation of the differentially
expressed genes in the four functional groups men-
tioned above.
Effect of dexamethasone on AM gene
expression (N vs. D)
When AM gene expression profiles between Normal
and Dex (N. vs. D) groups were compared, 200 genes
were found to be up-regulated and 144 genes were
found to be down-regulated by dexamethasone treat-
ment with an FDR ≤ 0.1 and FC ≥ 1.5 (Additional file 1,
Tables S1 and S2). The top ten up-regulated genes were
Cxcl2 (13.43), Fn1 (10.19), Ccl2 (9.99), Cd81 (9.07), Il1b
(8.65), Trf (8.55), Slc28a2 (8.24), Cd14 (8.10), Cdh17
(7.15), and Sdc4 (6.52); and the top ten down-regulated
ones were Hspa1a (-17.44), Hspa1b (-13.90), Hspb1
(-7.76), Hsph1 (-6.70), Tac1 (-6.16), Prkcb (-5.68), Atf3
(-4.91), Dnajb1 (-4.88), Fos (-4.54), and Ptprc (-3.92).
Values in the parentheses are fold changes.
Effect of Pneumocystis infection on alveolar
macrophage gene expression (Pc vs. D)
Comparison of the expression profiles between Dex-Pc
and Dex groups (Pc vs. D) revealed 116 genes up-regu-
lated and 140 genes down-regulated by Pneumocystis
Figure 2 Hierarchical clustering of differentially expressed
genes. ANOVA was first performed to identify genes that are
differentially expressed due to dexamethasone treatment or
Pneumocystis infection. Each lane represents the expression profile
of AMs from one rat. The first four lanes show the expression
profiles of AMs from the four Dex-Pc rats compared to that of Dex
rats, the middle four lanes display those of the four Dex rats
compared to that of Normal rats, and the remaining four lanes
represent those of the four Dex-Pc rats compared to that of Normal
rats. Red and blue colors indicate high and low expression levels,
respectively. Gray color indicates no change in expression levels.
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Page 5 of 16infection (Additional file 1, Tables S3 and S4) also with
the filter of FDR ≤ 0.1 and FC ≥ 1.5. The top ten up-
regulated genes were Cxcl10 (12.33), Spp1 (11.78),
S100A9 (11.55), Rsad2 (7.62), S100A8 (6.52), Nos2
(6.35), RT1-Bb (5.42), Lcn2 (5.36), RT1-Db1 (5.35), and
Srgn (5.34); and the top ten down-regulated ones were
Lgals1 (-4.24), Psat1 (-3.10), Tbc1d23 (-3.00), Gsta1
(-2.63), Car5b (-2.47), Xrcc5 (-2.35), Pdlim1 (-2.33),
Alcam (-2.29), Cidea (-2.27), and Pkib (-2.25).
Genes affected by dexamethasone but reversed by
Pneumocystis infection
Since both dexamethasone and P. carinii infection have
effects on gene expression in AMs, genes that were
affected differently were examined. Thirty-two genes
that were up regulated by dexamethasone treatment
were reversely down regulated by Pneumocystis infection
(Table 3). Another 32 genes that were up-regulated by
dexamethasone were further up-regulated by Pneumo-
cystis infection (Table 4). Nine genes that were down
regulated by dexamethasone were found to be up regu-
lated by Pneumocystis infection (Table 5), and twenty-
one genes that were down-regulated by dexamethasone
were further down-regulated by Pneumocystis infection
(Table 6).
Confirmation of microarray results by RT-PCR
To ensure that the expression levels of genes deter-
mined by the microarrays were correct, real-time RT-
PCR was performed on several selected target genes.
Results confirmed that Cat was down-regulated and
Cxcl10, Lcn2, Nos2, Sdc1, and Spp1 were up-regulated
(Table 7). Genes whose expression levels were not sig-
nificantly changed during PCP include Odc1, Smo, and
RPS8.
Discussion
In this study, DNA microarrays were used to study
effects of P. carinii infection on global gene expression
in AMs from rats. Since rats were immunosuppressed
with dexamethasone in order to establish Pneumocystis
infection, gene expression affected by dexamethasone
treatment was also investigated. A total of 1682 genes in
AMs were found to be affected by dexamethasone, and
Figure 3 Functions affected by dexamethasone or Pneumocystis infection. Cellular functions identified by IPA as being affected by
dexamethasone or Pneumocystis infection are illustrated with bar graphs based on the levels of -log(p-value), the higher the levels the more
significant of the effect. Black bars indicate functions affected by dexamethasone treatment, while open bars denote those affected by
Pneumocystis infection.
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infection with an FDR of ≤ 0.1. With a more stringent
filtering criteria of FDR ≤ 0.1 and FC ≥ 1.5, 200 genes
were found to be up regulated and 144 genes down
regulated by dexamethasone, and 115 genes were up
regulated and 137 genes down regulated by Pneumocys-
tis infection. Principle component analyses revealed that
the results generated from the twelve microarrays were
of excellent quality (Fig. 1). Because of costs, only one
time point (eight weeks after organism inoculation) was
examined in this study; this was a time when the Dex-
Pc animals were heavily infected with the organism.
An in vitro microarray study had been conducted pre-
viously using the human A549 alveolar epithelial cells
line [26]. The cells were incubated with P. carinii organ-
isms for 2 hr and then analyzed for global gene expres-
sion with the Affymetrix human U95 Arrays. The
results showed that some epithelial genes controlling
cell cycle progression such as the ras-related rho gene
and cyclin G-interacting protein gene were highly up-
regulated by P. carinii. TNF-inducible protein and the
pim oncogene that are involved in apoptosis signaling as
well as inflammatory cytokines and chemokines includ-
ing Gro-beta, IL-8, ICAM-1, MIP-3 and RANTES were
also up-regulated [26]. Another microarray study was
conducted by Hernandez-Novoa et al. [27]. They used
total RNA from lung cells of wild type and CD40L
knockout C57BL/6 mice infected with P. murina for
various length of time (7 to 41 days) and found that 349
genes related to immune responses were up-regulated in
wild type mice but not in CD40L-KO mice. The genes
involved in innate response were up-regulated first fol-
lowed by those involved in adaptive immunity. This
study revealed how healthy, immunocompetent hosts
respond to Pneumocystis infection [27]. In our study, we
used AMs from P. carinii-infected rats to investigate
how Pneumocystis affects AM functions by identifying
genes that are up- or down-regulated during Pneumo-
cystis infection.
IPA analyses showed that many cellular functions of
AMs were affected by Pneumocystis infection (Fig. 3).
Among them, antigen presentation, cell-mediated
immune response, humoral immune response and
inflammatory response were most profoundly affected.
Figure 4 Hierarchical clustering of differentially expressed genes related to the major functions of AMs. Genes involved in immune
response, inflammation, phagocytosis, and cell death were analyzed. Each lane represents the expression profile of AMs from one rat. For each
panel, the first four lanes show the expression profiles of AMs from the four Dex-Pc rats compared to that of Dex rats, the middle four lanes
display those of the four Dex rats compared to that of Normal rats, and the remaining four lanes represent those of the four Dex-Pc rats
compared to that of Normal rats. Red and blue colors indicate high and low expression levels, respectively. Gray color indicates no change in
expression levels.
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s u c ha sT a p 1 ,R T 1 - B ba n dR T 1 - D b 1 ,r e f l e c t st h e
attempts AMs make to activate the adaptive immune
responses. The observation that most genes involved in
both cell-mediated and inflammatory responses were up
regulated (Tables 1 and 2) implies that antigen presenta-
tion by AMs is functional during PCP. This postulation
is consistent with that of Hernandez-Novoa et al. [27].
The fact that PCP progresses despite activation of cell-
mediated immune response and inflammatory response
indicates that other cellular functions are disabled. Due
to the lack of appropriate antibodies, immunosuppres-
sion of rats is usually achieved by treatment with dexa-
methasone which is known to have an anti-
inflammatory and a wide range of side effects. Results of
this study revealed that in addition to the 1682 genes
mentioned above, functions related to cell death, small
molecule biochemistry (e.g., production of nitric oxide
and reactive oxygen species), and immunological disease
were most severely affected by dexamethasone (Fig. 3).
Dexamethasone and Pneumocystis infection were
found to have opposite effects on certain genes. Of the
32 genes that were up-regulated by dexamethasone but
down-regulated by Pneumocystis infection (Table 3),
cadherin 17 (Cdh17) and glutathione-S-transferase alpha
type2 (Gsta2) genes were most profoundly affected. Dex-
amethasone treatment increased Cdh17 expression by
7.15 fold, but Pneumocystis infection not only reversed
this effect but also decreased its expression by 1.61 fold.
Similarly, dexamethasone up-regulated Gsta2 by 4.77
fold, but Pneumocystis infection decreased it by 2.63
fold. Cadherin (calcium dependent adhesion molecule)
Table 1 Genes involved in the four major AM functions affected by Pneumocystis infection
Gene Pc vs. D Immune Response (23 genes) Inflammation (23 genes) Cell Death (29 genes) Phagocytosis (25 genes)
Lgals1 -4.24 ↓↓ ↓ ↓
Alcam -2.29 ↓↓ ↓ ↓
Cd55 -1.68 ↓↓ ↓ ↓
Cat -1.64 NA NA ↓↓
Hip1 -1.63 NA NA ↓↓
Hdac2 -1.61 NA NA ↓ NA
Bnip3l -1.58 NA NA ↓ NA
Nr1h3 -1.52 NA NA ↓ NA
Ppp6c -1.52 NA NA ↓ NA
Sod2 1.50 ↑↑ ↑ ↑
Socs3 1.67 ↑↑ ↑ ↑
Tap2 1.67 NA NA ↑ NA
Mmp14 1.78 NA ↑↑↑
Prf1 1.78 ↑↑ ↑ ↑
Il10 1.87 ↑↑ ↑ ↑
Mmp7 1.92 ↑↑ ↑ ↑
Mx2 1.94 ↑ NA NA ↑
Sell 1.97 ↑↑ ↑ ↑
Psmb9 2.14 ↑↑ ↑ ↑
Oas1a 2.32 ↑↑ ↑ ↑
Mmp8 2.34 NA ↑↑↑
Clu 2.37 ↑↑ ↑ ↑
Ccr1 2.40 ↑↑ ↑ ↑
Mx1 2.42 ↑↑ ↑ ↑
Il8rb 2.78 ↑↑ ↑ ↑
Ccr5 2.79 ↑↑ ↑ ↑
Gbp2 3.21 ↑↑ NA NA
Tap1 3.47 ↑ NA NA NA
Ccl5 3.58 ↑↑ ↑ ↑
Irf7 4.92 ↑↑ ↑ ↑
Nos2 6.35 ↑↑ ↑ ↑
Cxcl10 12.33 ↑↑ ↑ ↑
Values shown are fold changes. Pc vs. D: expression affected by Pneumocystis (Pc) infection compared to the Dex (D) control. Up arrow (↑): up regulated by
Pneumocystis infection; down arrow (↓): down regulated by Pneumocystis infection; NA: not applicable to the function.
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bly of the actin cytoskeleton [28]. Actin filaments are
linked to a-catenin and to the cell membrane through
vinculin which is linked to E-cadherin [29]. The
decrease in cadherin expression during PCP may be a
reason why AMs are defective in phagocytosis, as this
function requires the actin cytoskeleton. Glutathione
S-transferases (GSTs) link reduced glutathione via a
sulfhydryl group to electrophilic centers on a variety of
substrates [30]. This activity detoxifies compounds such
as peroxidized lipids [31] that are generated during oxi-
dative stress. The reduction in GST expression during
PCP may explain the reduction in AM number as a
decrease in GST expression would increase the concen-
tration of toxic molecules such as reactive oxygen spe-
cies [32] which can trigger apoptosis of AMs [33].
Equally important are genes that were down-regulated
by dexamethasone but up-regulated by Pneumocystis
infection. Among these genes (Spp1, Irf1, Cxcr4, Crp,
Il1rn, Irf8, RT1-Aw2, Ier3, and Ccnl1) (Table 5), the
secreted phosphoprotein 1 (Spp1) gene has the most
dramatic reversal by Pneumocystic infection followed by
interferon regulatory factor 1 (Irf1). The SPP1 protein is
also known as bone sialoprotein, early T-lymphocyte
activation (ETA-1), and most commonly osteopontin
(Opn). Opn is one of the most abundantly expressed
proteins in various lung diseases; it mediates diverse cel-
lular functions such as adhesion, migration, and survival
of several cell types including macrophages, T cells and
dentritic cells [34,35]. OPN also functions as a Th1
cytokine, promotes cell-mediated immune responses,
and plays a role in chronic inflammatory and autoim-
mune diseases and activation of immune cells [34]. Opn
can be cleaved by thrombin to expose the sequence
SVVYGLR which is a ligand of integrin receptors a4b1,
a9b1, and a9b4 that are present on monocytes, macro-
phages, neutrophils, T cells, and mast cells [36,37]. Up-
regulation of Opn during Pneumocystis infection may
reflect the action of AMs in an attempt to activate both
innate and adaptive immunities through the integrin
receptors. Opn expression has been found to be up-
regulated in AMs from smokers [38] and in titanium
dioxide-induced lung disease in rats [39]; it is consid-
ered as a biomarker for particle-induced lung disease
[39].
Both Irf-1 and Irf-8 genes were down-regulated by
dexamethasone (-1.52 and -1.61, respectively) but up
regulated by Pneumocystis infection (4.45 and 2.13 fold,
Table 2 Genes involved in the four major AM functions affected by both dexamethasone and Pneumocystis infection
Gene Pc vs. D D. vs. N Immune Response (16 genes) Inflammation (15 genes) Cell Death (22 genes) Phagocytosis (18 genes)
Gnptg -1.95 1.76 NA NA ↓ NA
Fah -1.80 1.50 NA NA ↓ NA
Mmp12 -1.70 2.50 NA ↓↓↓
Dnaja1 -1.67 -3.20 NA NA ↓↓
Tfp1 -1.65 1.98 ↓↓ NA ↓
Bloc1s2 -1.63 1.61 NA NA ↓ NA
Prkacb -1.56 2.03 NA NA ↓ NA
Alox5 -1.53 -3.07 ↓ NA ↓↓
Mgst1 -1.53 1.33 ↓↓ ↓ ↓
Hspa1b -1.13 -13.90 ↓↓ ↓ ↓
Pld1 1.076 -1.05 NA NA ↑↑
Xdh 1.74 5.55 NA NA ↑↑
Cd14 1.85 8.10 ↑↑ ↑ ↑
Irf8 2.13 -1.61 ↑↑ ↑ ↑
Il1b 2.26 8.65 ↑↑ ↑ ↑
Cxcl13 2.41 4.17 ↑↑ ↑ ↑
C1qb 2.64 2.04 ↑↑ NA NA
Cxcr4 3.60 -1.78 ↑↑ ↑ ↑
Fn1 4.20 10.19 ↑↑ ↑ ↑
Irf1 4.45 -1.52 ↑↑ ↑ ↑
Cd74 4.95 4.50 ↑↑ ↑ ↑
Srgn 5.34 3.39 ↑ NA ↑ NA
S100a9 11.55 2.65 ↑↑ ↑ ↑
Spp1 11.78 -1.72 ↑↑ ↑ ↑
Values shown are fold changes. D vs. N: expression affected by dexathamethasone (D) treatment compared to the normal control (N); Pc vs. D: expression
affected by Pneumocystis (Pc) infection compared to the Dex (D) control. Up arrow (↑): up regulated by Pneumocystis infection; down arrow (↓): down regulated
by Pneumocystis infection; NA: not applicable to the function.
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Page 9 of 16respectively). IRF-1 is a transcription factor originally
found to regulate the IFN-b gene family [40]. It also has
other functions such as acting as a tumor suppressor
[41], regulating the proliferation of smooth muscle cells,
and activating the expression of iNOS [42]. In addition,
IRF-1 induces transcription of genes such as PKR and
2’,5’-oligoadenylate synthetase [43,44] that are involved
in the defense against viral invasion. IRF-1 and IRF-8
are essential for proper functioning of mature macro-
phages. A defect in either gene results in the inability of
the host to mount Th1-mediated immune response due
to decreased production of IL-12 [45,46]. IRF-1 and
IRF-8 together regulate numerous genes. Using microar-
rays, Dror et al. showed that 265 genes in activated
macrophages are regulated by these two genes [47].
In addition to IRF1 and IRF8, IPA analyses revealed
that IL-1 and IL-10 also play a major role in the regula-
tion of gene expression during PCP. The expression of
IL-1b was up-regulated 8.65 fold by dexamethasone and
further up-regulated 2.26 fold by Pneumocystis infection
(Table 4). IL-1 is a pro-inflammatory cytokine. Its up-
regulation reflects the attempt of the host to combat the
infection by inflammation. Two forms of IL-1 exist: IL-
1a and IL-1b. IL-1 signals mainly through the type 1
IL-1 receptor (IL-1R1), leading to NF-B and c-jun acti-
vation and expression of cytokines such as TNF-a and
interferons, as well as other inflammation-related genes.
IL-10 is an anti-inflammatory cytokine. It can repress
the expression of inflammatory cytokines such as TNF-
a, IL-6, and IL-1 by activated macrophages. The
Figure 5 Subcellular localization of the products of differentially expressed genes during dexamethasone treatment or Pneumocystis
infection. The outer ring represents the cell membrane, and the inner oval circle denotes the nucleus; the space between these two structures
is the cytoplasm. Locations of the gene products are as indicated. Genes are shown in different colors, with red representing up-regulation and
green down-regulation. Genes that have a direct relationship between each other are connected by solid arrows, and those with indirect
relationships are linked by dotted arrows.
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Page 10 of 16expression of IL-10 was not affected by dexamethasone
treatment but was up-regulated 1.87 fold by Pneumocys-
tis infection (Table 1). IL-10 has been shown to inhibit
the expression of IL-1 receptor (IL-1R) gene [48] and
up-regulate the expression of IL-1R antagonist [49].
Both actions would block the function of IL-1, thus
decreasing production of pro-inflammatory cytokines.
The fact that pro-inflammatory cytokines are produced
despite IL-10 up-regulation suggests that the suppressive
effects of IL-10 on IL-1 expression may be blocked dur-
ing PCP.
Many (1705) genes are either up- or down-regulated
in AMs during PCP. It is surprising that even though
Pneumocystis is an extracellular pathogen, it is able to
affect so many genes without getting into the cells. A
number of cytokines such as TNF-a,I F N - g, IL-1, IL-10,
and IL-8 are over produced in the lung during PCP.
They may affect the expression of these genes. Pneumo-
cystis components such as the major surface glycopro-
tein or b-glucans that are present in the cell wall of the
organism in large quantities may have some effects.
Since Pneumocystis infection results in lung damage, cel-
lular components released may also cause differential
gene expression.
Among the top 10 up-regulated genes during PCP, the
chemokine (C-X-C motif) ligand 10 (Cxcl10) gene was
the most highly up-regulated one with a 12-fold increase
in expression. CXCL10 binds to the chemokine receptor
Table 3 Rat AM genes up-regulated by dexamethasone
but down-regulated by Pneumocystis infection
Gene D vs. N Pc vs. D
Cdh17 7.15 -1.61
Gsta2 4.77 -2.63
Fxyd2 3.79 -1.97
Hsd11b1 3.19 -1.60
Diablo 2.72 -1.74
Mmp12 2.50 -1.70
Ccng1 2.36 -1.63
Btd 2.28 -1.85
Gaa 2.27 -1.60
Agt 2.25 -1.51
Hacl1 2.22 -2.13
Prkacb 2.03 -1.56
Pcsk1 2.01 -1.80
Tfpi 1.98 -1.65
Atp6v1d 1.96 -1.65
Hsd17b12 1.89 -1.61
Vldlr 1.82 -2.17
Hspa9 1.72 -1.72
Aco1 1.71 -1.85
Atp6v1a 1.69 -1.58
Tceb1 1.62 -1.62
Bloc1s2 1.61 -1.63
Tbc1d23 1.60 -3.00
Aifm1 1.57 -1.57
Gpd2 1.57 -1.54
Ufsp2 1.57 -1.51
Gnptg 1.56 -1.95
Sqstm1 1.56 -1.79
Hook1 1.55 -1.64
Plod1 1.52 -1.65
PVR 1.51 -1.68
Fah 1.50 -1.80
Values shown are fold changes. D vs. N: expression affected by
dexathamethasone (D) treatment compared to the normal control (N); Pc vs.
D: expression affected by Pneumocystis (Pc) infection compared to the Dex (D)
control.
Table 4 Rat AM genes up-regulated by dexamethasone
and further up-regulated by Pneumocystis infection
Gene D vs. N Pc vs. D
S100a9 2.65 11.55
S100a8 2.50 6.52
RT1-Bb 3.98 5.42
RT1-Db1 1.65 5.35
Srgn 3.39 5.34
Ass1 1.62 5.28
Apoe 2.47 5.23
Cd74 4.50 4.95
RT1-Da 6.15 4.35
Fn1 10.19 4.20
Il1r2 3.50 3.14
Enpp3 2.08 2.88
Slc28a2 8.24 2.71
F3 2.87 2.67
Ccl2 9.99 2.65
C1qb 2.04 2.64
Pon1 3.05 2.29
Il1b 8.65 2.26
Nudt4 3.48 2.15
Cd14 8.10 1.85
Ptafr 1.59 1.84
Arg1 1.60 1.83
Ptgs2 2.01 1.83
Pstpip1 3.29 1.79
Pde4b 1.88 1.76
Xdh 5.55 1.74
Socs2 1.73 1.67
Bst1 2.34 1.55
Gda 2.26 1.55
Ctsk 3.68 1.54
Emb 1.71 1.53
Ptpn1 2.46 1.50
Values shown are fold changes. D vs. N: expression affected by
dexathamethasone (D) treatment compared to the normal control (N); Pc vs.
D: expression affected by Pneumocystis (Pc) infection compared to the Dex (D)
control.
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Page 11 of 16CXCR3 [50] and chemoattracts monocytes, macro-
phages, T cells, NK cells, and dendritic cells. It also pro-
motes adhesion of T cells to endothelial cells [51,52].
The high degree of CXCL10 up-regulation suggests the
attempts of the host to enhance AM phagocytosis. The
other top up-regulated genes include Spp1, S100A9,
Rsad2, S100A8, Nos2, RT1-Bb, Lcn2, RT1-Db1, and
Srgn. These genes encode the secreted phosphoprotein
1 (SPP1), calgranulin A and B complex (S100A8/
S100A9), radical S-adenosyl methionine domain con-
taining 2 (RSAD2), inducible nitric oxide synthase
(NOS2), class II MHC Bb,l i p o c a l i n - 2( L C N 2 ) ,c l a s sI I
MHC Db, and serglycin (SRGN) proteins, respectively.
As described above, the SPP1 protein plays a role in
the activation of both innate and adaptive immunity.
The calgranulin A and B complex (S100A8/S100A9)
have been shown to be a damage-associated pattern
molecule which mediates inflammatory responses and
recruits inflammatory cells to sites of tissue damage
[53]. It can also modulate polymerization of microtu-
bules during migration of phagocytes and induces
inflammatory responses in leucocytes and endothelial
cells [54,55]. Their up-regulation in expression during
PCP also shows the importance of phagocytosis in the
defense against Pneumocystis infection. The RSAD2 pro-
tein is also known as viperin. It is an endoplasmic reti-
culum-associated, interferon-inducible virus inhibitory
protein and has been shown to be required for optimal
Th2 responses and T-cell receptor-mediated activation
of NF-B and AP-1 [56]. The NOS2 (iNOS) protein is
responsible for the production of nitric oxide which is
an antimicrobial compound [57].
The lipocalin-2 protein (LCN2) is a component of
granules in neutrophils from tissues that are normally
exposed to microorganisms. Its level is increased during
inflammation [58]. LCN2 exerts bacteriostatic effects by
its ability to capture and deplete siderophores that are
small iron-binding molecules synthesized by certain bac-
teria as a means of iron acquisition [58]. Although
Pneumocystis siderophores have not been identified and
the role of LCN2 in PCP is unknown, iron is known to
be essential for the proliferation of Pneumocystis [59],
and deferoxamine, which is an iron chelator, has been
used to treat PCP in animal models [59].
Serglycin (SRGN) is a proteoglycan mainly produced
by hematopoietic and endothelial cells [60]. It plays an
important role in the formation of several types of
Table 6 Rat AM genes down-regulated by
dexamethasone and further down-regulated by
Pneumocystis infection
Gene D vs. N Pc vs. D
Alox5 -3.07 -3.07
Xrcc5 -1.92 -2.35
Hmgcs1 -1.78 -2.18
Gstm1 -1.72 -2.17
Hspa1a -17.44 -2.08
Ela1 -1.62 -2.02
Ivns1abp -1.88 -1.95
Igf1 -1.55 -1.81
Fbp1 -2.01 -1.77
Star -1.85 -1.75
Dusp5 -2.40 -1.68
Dnaja1 -3.20 -1.67
Rgc32 -2.87 -1.67
Pparg -1.56 -1.65
Dnajb1 -4.88 -1.59
Cd9 -1.54 -1.58
Ak3 -1.57 -1.57
St3gal2 -1.54 -1.56
Fcgrt -2.15 -1.55
Mtpn -1.62 -1.55
Cdc42ep3 -2.48 -1.52
Values shown are fold changes. D vs. N: expression affected by
dexathamethasone (D) treatment compared to the normal control (N); Pc vs.
D: expression affected by Pneumocystis (Pc) infection compared to the Dex (D)
control.
Table 7 Confirmation of fold changes by real-time RT-
PCR
Gene Microarray
a Real-time RT-PCR
b
Cat -1.64 -3.50
Cxcl10 12.33 11.03
Lcn2 5.36 15.47
Nos2 6.35 14.58
Sdc1 2.42 16.50
Spp1 11.78 16.32
aFold changes determined by microarray.
bFold changes determined by real-time RT-PCR
Table 5 Rat AM genes down-regulated by
dexamethasone but up-regulated by Pneumocystis
infection
Gene D vs. N Pc vs. D
Spp1 -1.72 11.78
Irf1 -1.52 4.45
Cxcr4 -1.78 3.60
Crp -1.86 3.23
Il1rn -1.83 2.84
Irf8 -1.61 2.13
RT1-Aw2 -1.97 2.00
Ier3 -1.86 1.63
Ccnl1 -2.20 1.57
Values shown are fold changes. D vs. N: expression affected by
dexathamethasone (D) treatment compared to the normal control (N); Pc vs.
D: expression affected by Pneumocystis (Pc) infection compared to the Dex (D)
control.
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Page 12 of 16storage granules, especially in mast cells [61]. Serglycin
can bind to a variety of molecules such as histamine,
chymase, tryptase, and carboxypeptidase in mast cells;
elastase in neutrophile; granzyme B in cytotoxic T cells;
plasminogen activator in endothelial cells; and TNF-a in
macrophages [60]. Serglycin is important for the reten-
tion of key inflammatory mediators inside storage gran-
ules and secretory vesicles [60]. Therefore, serglycin
plays a role in inflammation which is also a host defense
mechanism. RT1-Bb and RT1-Db1 are class II MHC
molecules [62] and are involved in antigen presentation
as described above. Their up-regulation also suggests
the attempts of AMs to activate adaptive immunity.
Among the ten most down-regulated genes, the
expression of the lectin, galactoside-binding, soluble, 1
(Lgals1) gene is most severely reduced by Pneumocystis
infection. Lgals1 encodes galectin-1 which is an endo-
genous lectin that can trigger lymphocyte apoptosis [63].
Its down-regulation reflects the attempts of AMs to sur-
vive. The phosphoserine aminotransferase (Psat1) gene
was the second most down-regulated gene. PSAT1 is
over-expressed in colon tumors [64], but its role in PCP
cannot be speculated due to limited information on its
function. TBC1D3 is a member of the TBC1 domain
family of proteins that stimulates the intrinsic GTPase
activity of RAB5A, an essential actor in early endosome
trafficking [65]. Its down-regulation would affect the
phagocytic function of AMs. CAR5B is the mitochon-
drial form of carbonic anhydrase responsible for the
inter-conversion of carbon dioxide and bicarbonate to
maintain acid-base balance in blood and other tissues,
and to help transport carbon dioxide out of tissues [66].
The active site of most carbonic anhydrases contains a
zinc ion; therefore, they are classified as metalloenzymes.
Although it was one of the most severely down-regu-
lated genes, its role in PCP is not clear.
The X-ray repair complementing defective repair in
Chinese hamster cells 5 (Xrcc5) gene encodes the Ku80
protein which is a helicase involved in DNA double-
strand-break repair and chromatin remodeling [67].
Ku80 is also expressed on the surface of different types
of cells and functions as an adhesion receptor for fibro-
nectin [68] which enhances the interaction of AMs with
Pneumocystis organisms [69]. Its down-regulation can be
viewed as a double-edged sword as the inability of AMs
to repair damaged DNA may trigger apoptosis thus
decreasing their numbers, and the decrease in fibronec-
tin receptor may decrease the phagocytic activity of
AMs.
PDZ/LIM genes encode a group of proteins with
diverse biological roles. In mammalian cells, there are
ten genes that encode both a PDZ domain and one or
several LIM domains [70]. All PDZ and LIM domain
proteins can associate with and influence the actin
cytoskeleton [71]. Down-regulation of any of these
genes would affect the integrity of the actin cytoskeleton
which plays a major role in phagocytosis. The activated
leukocyte cell adhesion molecule (ALCAM) is an immu-
noglobulin superfamily cell adhesion molecule. It med-
iates both heterophilic (ALCAM-CD6) and homophilic
(ALCAM-ALCAM) cell-cell interactions [72]. Its down-
regulation in expression would affect the movement and
thus phagocytic function of AMs.
The cell death-inducing DFF45-like effector (CIDE)
family proteins include CIDEA, CIDEB, and CIDEC.
These proteins are important regulators of energy
homeostasis and are closely linked to the development
of metabolic disorders including obesity, diabetes, and
liver steatosis. CIDEA may initiate apoptosis by disrupt-
ing a complex consisting of the 40-kDa caspase-3-acti-
vated nuclease (DFF40/CAD) and its 45-kDa inhibitor
(DFF45/ICAD) [73]. Its down-regulation can be viewed
as the attempt of AMs to fight for survival by decreasing
CIDEA-mediated apoptosis.
Conclusions
Our data provide the first comprehensive description of
t h er e s p o n s eo fA M st oPneumocystis infection using
microarray and revealed a wide variety of genes and cel-
lular functions that are affected by dexamethasone or
Pneumocystis infection. Dexamethasone will continue to
be used for immunosuppression if the rat PCP model is
to be used for study of Pneumocystis infection. Knowing
what dexamethasone will do to the cells will give inves-
tigators a better insight in studying the effect of Pneu-
mocystis infection on gene expression and function of
AMs. This study also revealed many defects of AMs
that may occur during Pneumocystis infection, as many
genes whose expressions are affected by the infection.
Investigation of these genes will allow us to better
understand the mechanisms of pathogenesis of PCP.
Additional file 1: Table S1. Rat alveolar macrophage genes up-
regulated by dexamethasone. Table S2. Rat alveolar macrophage genes
down-regulated by dexamethasone. Table S3. Rat alveolar macrophage
genes up-regulated by Pneumocystis infection. Table S4. Rat alveolar
macrophage genes down-regulated by Pneumocystis infection.
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